Date: 2017-04-21
Type of information: Capital increase
Company: Galapagos (Belgium)
Investors:
Amount: €363.9 million
Funding type: capital increase
Planned used:
Others: • On April 21, 2017, Galapagos announced a share capital increase as a result of a public offering of American Depositary Shares. In accordance with Belgian transparency legislation, Galapagos notes that its total share capital currently amounts to €274,854,440.18; the total number of securities conferring voting rights is 50,815,648, which is also the total number of voting rights, and all securities conferring voting rights and all voting rights are of the same category. The total number of rights (warrants) to subscribe to not yet issued securities conferring voting rights is 3,369,337, which equals the total number of voting rights that may result from the exercise of these warrants. Galapagos does not have any convertible bonds or shares without voting rights outstanding. • On April 21, 2017, Galapagos announced the closing of its underwritten public offering of 4,312,500 American Depositary Shares, at a price of $90.00 per ADS, before underwriting discounts, for gross proceeds of €363.9 million. This includes the full exercise of the underwriters' option to purchase additional ADSs. All of the ADSs were offered by Galapagos. Each of the ADSs offered represents the right to receive one ordinary share. Morgan Stanley acted as sole book-running manager for the public offering. The securities were offered pursuant to an automatically effective shelf registration statement that was previously filed with the Securities and Exchange Commission.
Therapeutic area:
